Results 341 to 350 of about 1,036,661 (382)
Some of the next articles are maybe not open access.

PAROXETINE AND THE FDA

Journal of the American Academy of Child & Adolescent Psychiatry, 2004
On June 19, 2003 the U.S. Food and Drug Administration (FDA) released a statement regarding the antidepressant Paxil® for pediatric depression. The primary reason for the statement was new data indicating a possible increased risk of suicidal thinking and suicidal attempts in children and adolescents under the age of 18 treated with the drug Paxil for ...
openaire   +3 more sources

Partnering with the FDA

2021
The US Food and Drug Administration (FDA) has existed for more than 150 years, traced back to the creation of the Agricultural Division in 1848. Although the mission and infrastructure of the FDA have evolved to a great extent, the basic principle has remained the same – to protect the public health.
Katie McCarthy, Niki Gallo
openaire   +2 more sources

FDA Perspective

The Annals of Thoracic Surgery, 1996
In this article, based on a presentation before The Society of Thoracic Surgeons, D. Bruce Burlington, MD, director of the United States Food and Drug Administration's Center for Devices and Radiological Health, describes the role of the Center in regulating medical devices.
openaire   +3 more sources

Trends in the approval of cancer therapies by the FDA in the twenty-first century

Nature reviews. Drug discovery, 2023
Emma C. Scott   +12 more
semanticscholar   +1 more source

2022 FDA approvals

Nature reviews. Drug discovery, 2023
Asher Mullard
semanticscholar   +1 more source

FDA approves 100th monoclonal antibody product

Nature reviews. Drug discovery, 2021
Asher Mullard
semanticscholar   +1 more source

Esketamine for Treatment-Resistant Depression - First FDA-Approved Antidepressant in a New Class.

New England Journal of Medicine, 2019
Esketamine for Treatment-Resistant Depression The FDA has approved esketamine, the first antidepressant in a new class, for treatment-resistant depression.
Jean Kim   +4 more
semanticscholar   +1 more source

FDA update

Epilepsy Research, 2006
This report addresses: (1) a general update of FDA activity in areas relevant to AED development; (2) an update on issues relevant to the development of AEDs in the pediatric population; and (3) an update on the Agency's approach to the evaluation of AEDs as monotherapy.
openaire   +2 more sources

2021 FDA approvals

Nature reviews. Drug discovery, 2022
Asher Mullard
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy